title: MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cells.
abstract: CD4 Th cells are critical to the development of coordinated immune responses to infections and tumors. Th cells are activated through interactions of the TCR with MHC class II complexed with peptide. T cell activation is dependent on the density of MHC peptide complexes as well as the duration of interaction of the TCR with APCs. In this study, we sought to determine whether MHC class II peptides could be modified with amino acid sequences that facilitated uptake and presentation with the goal of improving Th cell activation in vitro and in vivo. A model epitope derived from the murine folate receptor α, a self- and tumor Ag, was modified at its carboxyl terminus with the invariant chain-derived Ii-Key peptide and at its N terminus with a peptide that enhances uptake of Ag by APC. Modification of a peptide resulted in enhanced generation of high-avidity murine folate receptor α T cells that persisted in vivo and homed to sites of Ag deposition. The nesting approach was epitope and species independent and specifically excluded expansion of CD4 regulatory T cells. The resulting Th cells were therapeutic, enhanced in vivo helper activity and had an increased ability to resist tolerizing immune microenvironments. In addition to improved immunoadjuvants, this epitope modification strategy may be useful for enhancing ex vivo and in vivo generation of Th cells for preventing and treating diseases.
authors: Department of Immunology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
authors: Courtney L
authors: CL
authors: Erskine
authors: Christopher J
authors: CJ
authors: Krco
authors: Karen E
authors: KE
authors: Hedin
authors: Nancy D
authors: ND
authors: Borson
authors: Kimberly R
authors: KR
authors: Kalli
authors: Marshall D
authors: MD
authors: Behrens
authors: Sabrina M
authors: SM
authors: Heman-Ackah
authors: Eric
authors: E
authors: von Hofe
authors: Peter J
authors: PJ
authors: Wettstein
authors: Mansour
authors: M
authors: Mohamadzadeh
authors: Keith L
authors: KL
authors: Knutson
references: Nature. 2006 May 11;441(7090):235-8
references: 16648838
references: J Immunol. 2008 Jun 15;180(12):8386-92
references: 18523306
references: J Immunol Methods. 2008 Feb 29;331(1-2):127-39
references: 18206159
references: Cancer Immunol Immunother. 2005 Aug;54(8):721-8
references: 16010587
references: Virology. 2007 Feb 5;358(1):98-108
references: 16996102
references: J Immunol. 2004 Jun 15;172(12):7425-31
references: 15187120
references: Proc Natl Acad Sci U S A. 1995 May 23;92(11):5042-6
references: 7761445
references: J Exp Med. 2005 May 2;201(9):1435-46
references: 15851485
references: Cancer Res. 2004 Feb 1;64(3):1146-51
references: 14871850
references: J Immunother. 2005 Jul-Aug;28(4):352-8
references: 16000953
references: J Immunol. 2006 Jul 1;177(1):84-91
references: 16785502
references: Eur J Immunol. 1995 Jun;25(6):1693-702
references: 7614997
references: Immunity. 2006 Aug;25(2):213-24
references: 16919488
references: Eur J Immunol. 1998 May;28(5):1524-33
references: 9603457
references: J Clin Oncol. 2006 Sep 10;24(26):4254-61
references: 16908932
references: J Clin Invest. 2001 Feb;107(4):477-84
references: 11181647
references: Clin Exp Immunol. 2010 Feb;159(2):109-19
references: 19912252
references: Nucleic Acids Res. 2008 Dec;36(21):e140
references: 18835849
references: Immunity. 2002 Nov;17(5):549-60
references: 12433362
references: Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18460-5
references: 19015529
references: J Clin Oncol. 2008 Jul 10;26(20):3426-33
references: 18612158
references: Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4824-9
references: 15772168
references: J Immunol. 2006 May 15;176(10):6340-6
references: 16670346
references: J Immunol. 2004 Apr 1;172(7):4575-82
references: 15034075
references: Infect Immun. 2001 Aug;69(8):4839-45
references: 11447158
references: Int J Cancer. 2006 Jul 15;119(2):243-50
references: 16453285
references: Trends Immunol. 2003 May;24(5):264-8
references: 12738421
references: J Exp Med. 2005 May 16;201(10):1591-602
references: 15883172
references: Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19954-9
references: 18042727
references: Mol Immunol. 2008 Apr;45(7):1935-43
references: 18054387
references: J Virol. 2005 Sep;79(17):11457-66
references: 16103196
references: Cancer Immunol Immunother. 2004 Jun;53(6):490-6
references: 14740174
references: Eur J Immunol. 2011 May;41(5):1334-43
references: 21469103
references: J Immunol. 2010 Jul 1;185(1):174-82
references: 20525892
references: Blood. 2008 Feb 1;111(3):1472-9
references: 18029553
references: Front Biosci. 2006 Jan 01;11:46-58
references: 16146713
references: Vaccine. 2000 Jun 1;18(24):2693-7
references: 10781856
references: J Exp Med. 2002 Jun 3;195(11):1407-18
references: 12045239
references: Annu Rev Immunol. 2010;28:445-89
references: 20192806
references: J Clin Oncol. 2002 Jun 1;20(11):2624-32
references: 12039923